Publication:
Coronavac covid-19 vaccine-induced anaphylaxis: Clinical characteristics and revaccination outcomes

Simple item page
dc.contributor.authorLaisuan W.
dc.contributor.authorWongsa C.
dc.contributor.authorChiewchalermsri C.
dc.contributor.authorThongngarm T.
dc.contributor.authorRerkpattanapipat T.
dc.contributor.authorIamrahong P.
dc.contributor.authorRuangwattanachok C.
dc.contributor.authorNanthapisal S.
dc.contributor.authorSompornrattanaphan M.
dc.date.accessioned2022-03-10T13:17:01Z
dc.date.available2022-03-10T13:17:01Z
dc.date.issued2021
dc.date.issuedBE2564
dc.description.abstractAnaphylaxis to CoronaVac, an inactivated vaccine against COVID-19, is extremely rare. We report 12 cases of anaphylaxis after CoronaVac administration, focusing on clinical characteristics and management outcomes. Skin test and graded vaccine challenge were successfully performed in our cases and might be considered if an inactivated vaccine is the only remaining option. © 2021 Laisuan et al. This work is published and licensed by Dove Medical Press Limited.
dc.format.mimetypeapplication/pdf
dc.identifier.citationJournal of Asthma and Allergy. Vol 14, No. (2021), p.1209-1215
dc.identifier.doi10.2147/JAA.S333098
dc.identifier.issn11786965
dc.identifier.other2-s2.0-85118542385
dc.identifier.urihttps://hdl.handle.net/20.500.14740/7961
dc.language.isoeng
dc.rights.holderScopus
dc.subject.otherCoronavac
dc.subject.otherImmunoglobulin G
dc.subject.otherInactivated vaccine
dc.subject.otherAdult
dc.subject.otherAnaphylaxis
dc.subject.otherArticle
dc.subject.otherBurkholderia pseudomallei
dc.subject.otherClinical article
dc.subject.otherComplement activation
dc.subject.otherCoronavirus disease 2019
dc.subject.otherDrug hypersensitivity
dc.subject.otherFatigue
dc.subject.otherFemale
dc.subject.otherFever
dc.subject.otherGenetic variation
dc.subject.otherHeadache
dc.subject.otherHuman
dc.subject.otherIntensive care unit
dc.subject.otherMiddle aged
dc.subject.otherMortality
dc.subject.otherMyalgia
dc.subject.otherNose polyp
dc.subject.otherPetechia
dc.subject.otherPrick test
dc.subject.otherRevaccination
dc.subject.otherShellfish allergy
dc.subject.otherTreatment outcome
dc.subject.otherVaccination
dc.titleCoronavac covid-19 vaccine-induced anaphylaxis: Clinical characteristics and revaccination outcomes
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85118542385&doi=10.2147%2fJAA.S333098&partnerID=40&md5=ea53204c87f5a790f324985731619e81

Files

Collections

Scopus: Year 1983-2021